| Description |
1 online resource |
| Contents |
TITLE PAGE ; COPYRIGHT PAGE ; CONTENTS; PREFACE ; LIST OF CONTRIBUTORS; CHAPTER 1 DOWNSTREAM PROCESSING OF MONOCLONAL ANTIBODIES: CURRENT PRACTICES AND FUTURE OPPORTUNITIES; 1.1 INTRODUCTION; 1.2 A BRIEF HISTORY OF CURRENT GOOD MANUFACTURING PROCESS mAb AND INTRAVENOUS IMMUNOGLOBULIN PURIFICATION; 1.3 CURRENT APPROACHES IN PURIFICATION PROCESS DEVELOPMENT: IMPACT OF PLATFORM PROCESSES; 1.4 TYPICAL UNIT OPERATIONS AND PROCESSING ALTERNATIVES; 1.5 VLS PROCESSES: TON-SCALE PRODUCTION AND BEYOND ; 1.6 PROCESS VALIDATION; 1.7 PRODUCT LIFE CYCLE MANAGEMENT; 1.8 FUTURE OPPORTUNITIES; 1.9 CONCLUSIONS |
|
ACKNOWLEDGMENTSREFERENCES; CHAPTER 2 THE DEVELOPMENT OF ANTIBODY PURIFICATION TECHNOLOGIES; 2.1 INTRODUCTION; 2.2 PURIFICATION OF ANTIBODIES BY CHROMATOGRAPHY BEFORE PROTEIN A; 2.3 ANTIBODY PURIFICATION AFTER 1975; 2.4 ADDITIONAL TECHNOLOGIES FOR ANTIBODY PURIFICATION; 2.5 PURIFICATION OF mAbs APPROVED IN NORTH AMERICA AND EUROPE; 2.6 CURRENT ANTIBODY PROCESS TECHNOLOGY DEVELOPMENTS; ACKNOWLEDGMENTS; REFERENCES; CHAPTER 3 HARVEST AND RECOVERY OF MONOCLONAL ANTIBODIES: CELL REMOVAL AND CLARIFICATION; 3.1 INTRODUCTION; 3.2 CENTRIFUGATION; 3.3 MICROFILTRATION; 3.4 DEPTH FILTRATION |
|
3.5 FLOCCULATION3.6 ABSOLUTE FILTRATION; 3.7 EXPANDED BED ADSORPTION CHROMATOGRAPHY; 3.8 HARVESTING IN SINGLE?USE MANUFACTURING; 3.9 COMPARISON OF HARVEST AND CLARIFICATION UNIT OPERATIONS; REFERENCES; CHAPTER 4 NEXT-GENERATION CLARIFICATION TECHNOLOGIES FOR THE DOWNSTREAM PROCESSING OF ANTIBODIES ; 4.1 INTRODUCTION; 4.2 IMPURITY PROFILES IN CELL CULTURES; 4.3 PRECIPITATION; 4.3.1 Acid Precipitation; 4.3.2 Caprylic Acid Precipitation; 4.3.3 PEG Precipitation; 4.3.4 Cold Ethanol Precipitation; 4.4 AFFINITY PRECIPITATION; 4.5 FLOCCULATION; 4.5.1 Anionic Flocculation; 4.5.2 Cationic Flocculation |
|
4.5.3 Multimodal Flocculation4.6 TOXICITY OF FLOCCULANTS AND PRECIPITANTS AND THEIR RESIDUAL CLEARANCE; 4.7 DEPTH FILTRATION; 4.7.1 Improvements in Depth Filtration Technology; 4.7.2 Impurity Removal by Depth Filtration; 4.7.3 Virus Clearance by Depth Filtration; 4.8 CONSIDERATIONS FOR THE IMPLEMENTATION OF NEW CLARIFICATION TECHNOLOGIES; 4.9 CONCLUSIONS AND FUTURE PERSPECTIVES; ACKNOWLEDGMENTS; REFERENCES; CHAPTER 5 PROTEIN A-BASED AFFINITY CHROMATOGRAPHY ; 5.1 INTRODUCTION; 5.2 PROPERTIES OF PROTEIN A AND COMMERCIALLY AVAILABLE PROTEIN A RESINS; 5.2.1 Protein A Structure |
|
5.2.2 Protein A-Immunoglobulin G Interaction5.2.3 Stoichiometry of Protein A-IgG Binding; 5.2.4 Protein A Stability; 5.2.5 Commercial Protein A Resins; 5.2.6 Static Capacity; 5.2.7 Dynamic Binding Capacity; 5.2.8 Leaching; 5.2.9 Production Rates; 5.3 PROTEIN A CHROMATOGRAPHY STEP DEVELOPMENT; 5.3.1 Loading/Binding; 5.3.2 Wash Development; 5.3.3 Elution; 5.3.4 Stripping; 5.3.5 Regeneration and CIP; 5.4 ADDITIONAL CONSIDERATIONS DURING DEVELOPMENT AND SCALE?UP; 5.4.1 Controlling HMW Aggregate Formation; 5.4.2 Removal of Soluble HMW Contaminants; 5.4.3 Turbidity; 5.5 VIRUS REMOVAL/INACTIVATION |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Print version record and CIP data provided by publisher |
| Subject |
Monoclonal antibodies -- Purification
|
|
Biochemical engineering.
|
|
Antibodies, Monoclonal -- isolation & purification
|
|
Antibodies, Monoclonal -- therapeutic use
|
|
Chromatography -- methods
|
|
Technology, Pharmaceutical -- methods
|
|
MEDICAL -- Pharmacology.
|
|
Biochemical engineering
|
| Form |
Electronic book
|
| Author |
Gottschalk, Uwe, editor
|
| LC no. |
2017006811 |
| ISBN |
9781119126928 |
|
1119126924 |
|
9781119126935 |
|
1119126932 |
|
9781119126942 |
|
1119126940 |
|
